2023 Q4 Form 20-F Financial Statement

#000156276224000080 Filed on April 05, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2021
Revenue $60.02M $262.1M $214.2M
YoY Change -20.72% -9.61% 26.22%
Cost Of Revenue $24.85M $99.11M $80.33M
YoY Change 11.05% 25.49% -19.19%
Gross Profit $35.17M $163.0M $133.9M
YoY Change -34.05% -22.75% 90.17%
Gross Profit Margin 58.6% 62.19% 62.5%
Selling, General & Admin $8.697M $34.28M $30.62M
YoY Change 16.46% 14.74% -12.0%
% of Gross Profit 24.73% 21.03% 22.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.51M $49.79M $40.49M
YoY Change -5.89% 14.91% -5.83%
% of Gross Profit 32.72% 30.54% 30.25%
Operating Expenses $20.21M $84.07M $71.12M
YoY Change 2.58% 14.84% -8.47%
Operating Profit $14.97M $78.93M $62.76M
YoY Change -55.51% -42.72% -959.74%
Interest Expense -$5.912M -$34.50M -$20.69M
YoY Change -23.63% 50.43% -3.31%
% of Operating Profit -39.51% -43.71% -32.97%
Other Income/Expense, Net -$761.0K -$308.0K -$307.0K
YoY Change -25.78% 2.33%
Pretax Income $9.382M $49.84M $57.39M
YoY Change -63.47% -58.14% -142.77%
Income Tax
% Of Pretax Income
Net Earnings $7.940M $44.08M $57.39M
YoY Change -67.24% -61.1% -142.77%
Net Earnings / Revenue 13.23% 16.82% 26.79%
Basic Earnings Per Share $0.44 $0.64
Diluted Earnings Per Share $0.07 $0.41 $676.4K
COMMON SHARES
Basic Shares Outstanding 113.1M shares 100.2M shares 81.12M shares
Diluted Shares Outstanding 101.9M shares 84.86M shares

Balance Sheet

Concept 2023 Q4 2023 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.6M $161.6M $110.3M
YoY Change 12.27% 12.27% 75.34%
Cash & Equivalents $161.6M $161.6M $110.3M
Short-Term Investments $20.73M $20.73M
Other Short-Term Assets $19.90M $19.90M $5.484M
YoY Change 12.84% 12.84% -82.08%
Inventory $5.056M $5.056M $6.089M
Prepaid Expenses
Receivables $5.870M $6.019M $3.784M
Other Receivables $149.0K $0.00 $0.00
Total Short-Term Assets $181.5M $181.5M $125.6M
YoY Change 12.33% 12.33% 20.0%
LONG-TERM ASSETS
Property, Plant & Equipment $924.5M $924.5M $666.3M
YoY Change -7.25% -7.25% -9.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $44.82M $44.82M $7.644M
YoY Change 443.22% 443.22%
Other Assets $15.63M $15.63M $42.37M
YoY Change -4.72% -4.72% 41.7%
Total Long-Term Assets $984.9M $984.9M $716.3M
YoY Change -3.57% -3.57% -6.69%
TOTAL ASSETS
Total Short-Term Assets $181.5M $181.5M $125.6M
Total Long-Term Assets $984.9M $984.9M $716.3M
Total Assets $1.166B $1.166B $842.0M
YoY Change -1.4% -1.4% -3.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.663M $9.663M $9.777M
YoY Change -14.05% -14.05% 13.69%
Accrued Expenses $12.42M $12.42M $7.878M
YoY Change 2.32% 2.32% -24.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $49.51M $58.73M $41.15M
YoY Change -45.89% -41.44% 4.97%
Total Short-Term Liabilities $85.13M $85.13M $65.13M
YoY Change -35.29% -35.29% 5.73%
LONG-TERM LIABILITIES
Long-Term Debt $642.8M $642.8M $382.5M
YoY Change -3.12% -3.12% 0.37%
Other Long-Term Liabilities $34.62M $34.62M $1.097M
YoY Change 7.68% 7.68% -8.58%
Total Long-Term Liabilities $677.4M $677.4M $383.6M
YoY Change -2.62% -2.62% 0.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $85.13M $85.13M $65.13M
Total Long-Term Liabilities $677.4M $677.4M $383.6M
Total Liabilities $677.4M $677.4M $448.8M
YoY Change -2.62% -2.62% 1.12%
SHAREHOLDERS EQUITY
Retained Earnings -$613.9M
YoY Change 6.76%
Common Stock $1.131M
YoY Change 10.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $489.0M $489.0M $393.2M
YoY Change
Total Liabilities & Shareholders Equity $1.166B $1.166B $842.0M
YoY Change -1.4% -1.4% -3.49%

Cashflow Statement

Concept 2023 Q4 2023 2021
OPERATING ACTIVITIES
Net Income $7.940M $44.08M $57.39M
YoY Change -67.24% -61.1% -142.77%
Depreciation, Depletion And Amortization $11.51M $49.79M $40.49M
YoY Change -5.89% 14.91% -5.83%
Cash From Operating Activities -$2.220M $70.38M $89.71M
YoY Change -101.4% -55.7% 421.54%
INVESTING ACTIVITIES
Capital Expenditures $29.73M -$18.99M
YoY Change -87.09% 211.36%
Acquisitions
YoY Change
Other Investing Activities $31.03M $24.93M $32.36M
YoY Change -111.36% -159.17% 94.92%
Cash From Investing Activities $31.03M $24.93M $13.36M
YoY Change -111.36% -109.13% 27.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$45.12M
YoY Change 275.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.74M -71.15M -59.19M
YoY Change -119.73% -183.82% -19.03%
NET CHANGE
Cash From Operating Activities -2.220M 70.38M 89.71M
Cash From Investing Activities 31.03M 24.93M 13.36M
Cash From Financing Activities -16.74M -71.15M -59.19M
Net Change In Cash 12.06M 24.16M 43.88M
YoY Change -141.09% -182.3% -196.65%
FREE CASH FLOW
Cash From Operating Activities -$2.220M $70.38M $89.71M
Capital Expenditures $29.73M -$18.99M
Free Cash Flow $40.65M $108.7M
YoY Change -156.9% 366.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102653619 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113065725 shares
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001318885
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q4 dsx Class Of Warrant Or Right Additional Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightAdditionalNumberOfSecuritiesCalledByEachWarrantOrRight
0.5 shares
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#AssetImpairmentCharges
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-32458
CY2023 dei Entity Registrant Name
EntityRegistrantName
DIANA SHIPPING INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
1T
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Pendelis 16
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
175 64 Palaio Faliro
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Athens
CY2023 dei Entity Address Country
EntityAddressCountry
GR
CY2023 dei Contact Personnel Name
ContactPersonnelName
Mr. Ioannis Zafirakis
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
113065725 shares
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Name
AuditorName
Ernst and Young
CY2023 dei Auditor Firm
AuditorFirmId
1457
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101592000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76428000 usd
CY2023Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
40000000 usd
CY2022Q4 us-gaap Other Short Term Investments
OtherShortTermInvestments
46500000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5870000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6126000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
149000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
216000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
5056000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4545000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8696000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6749000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
20729000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
0 usd
CY2023Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
129000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
0 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
182221000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
140564000 usd
CY2023Q4 dsx Advances For Vessel Acqusitions
AdvancesForVesselAcqusitions
0 usd
CY2022Q4 dsx Advances For Vessel Acqusitions
AdvancesForVesselAcqusitions
24123000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
900192000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
949616000 usd
CY2023Q4 dsx Property And Equipment Net
PropertyAndEquipmentNet
24282000 usd
CY2022Q4 dsx Property And Equipment Net
PropertyAndEquipmentNet
22963000 usd
CY2023Q4 dsx Total Fixed Assets
TotalFixedAssets
924474000 usd
CY2022Q4 dsx Total Fixed Assets
TotalFixedAssets
996702000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
20000000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
21000000 usd
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Noncurrent
OtherReceivableAfterAllowanceForCreditLossNoncurrent
319000 usd
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Noncurrent
OtherReceivableAfterAllowanceForCreditLossNoncurrent
0 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
15769000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
506000 usd
CY2023Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
8318000 usd
CY2022Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
7744000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000 usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
15278000 usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
16302000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
984189000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1042355000 usd
CY2023Q4 us-gaap Assets
Assets
1166410000 usd
CY2022Q4 us-gaap Assets
Assets
1182919000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
49512000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
91495000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
9221000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8802000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9663000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11242000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
759000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
136000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12416000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12134000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3563000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7758000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
85134000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
131567000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
461131000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
431016000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
122908000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
132129000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
568000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 usd
CY2023Q4 dsx Warrant Liability Non Current Liabilities
WarrantLiabilityNonCurrentLiabilities
6332000 usd
CY2022Q4 dsx Warrant Liability Non Current Liabilities
WarrantLiabilityNonCurrentLiabilities
0 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1316000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
879000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
592255000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
564024000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
26000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
26000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113065725 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102653619 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1131000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1027000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1101425000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1061015000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
308000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
253000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-613869000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-574993000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
489021000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
487328000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1166410000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1182919000 usd
CY2023 us-gaap Revenues
Revenues
262098000 usd
CY2022 us-gaap Revenues
Revenues
289972000 usd
CY2021 us-gaap Revenues
Revenues
214203000 usd
CY2023 us-gaap Direct Operating Costs
DirectOperatingCosts
13621000 usd
CY2022 us-gaap Direct Operating Costs
DirectOperatingCosts
6942000 usd
CY2021 us-gaap Direct Operating Costs
DirectOperatingCosts
5570000 usd
CY2023 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
85486000 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
72033000 usd
CY2021 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
74756000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
49785000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43326000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40492000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32968000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29367000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29192000 usd
CY2023 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1313000 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
511000 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1432000 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5323000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2850000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1360000 usd
CY2023 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2022 us-gaap Insurance Recoveries
InsuranceRecoveries
1789000 usd
CY2021 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1464000 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
265000 usd
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-603000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
85712000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
142697000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
63518000 usd
CY2023 us-gaap Interest Expense
InterestExpense
49331000 usd
CY2022 us-gaap Interest Expense
InterestExpense
27419000 usd
CY2021 us-gaap Interest Expense
InterestExpense
20239000 usd
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
8170000 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
2737000 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
176000 usd
CY2023 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-439000 usd
CY2022 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
0 usd
CY2021 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-748000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-435000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-980000 usd
CY2023 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2022 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15252000 usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
844000 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2023 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
1502000 usd
CY2022 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
589000 usd
CY2021 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
0 usd
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2813000 usd
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1583000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-262000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
894000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-333000 usd
CY2023 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-35868000 usd
CY2022 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-23634000 usd
CY2021 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-6124000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
49844000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
119063000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
57394000 usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44075000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
113294000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51625000 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100166629 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80061040 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81121781 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101877142 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83318901 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84856840 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
49844000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
119063000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
57394000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
55000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
182000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
49899000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
119245000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
57396000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
428570000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
57394000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
254000 usd
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
7442000 usd
CY2021 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
45369000 usd
CY2021 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
5769000 usd
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8820000 usd
CY2021 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
40509000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
393195000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
119063000 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
9282000 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3799000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5322000 usd
CY2022 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
67853000 usd
CY2022 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
5769000 usd
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
79812000 usd
CY2022 us-gaap Dividends Paidinkind
DividendsPaidinkind
18189000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
182000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
487328000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
49844000 usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
9938000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22846000 usd
CY2023 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
7730000 usd
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
64276000 usd
CY2023 dsx Increase Decrease In Equity From Warrants
IncreaseDecreaseInEquityFromWarrants
-7914000 usd
CY2023 us-gaap Dividends Paidinkind
DividendsPaidinkind
10761000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
55000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
489021000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
49844000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
119063000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
57394000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
49785000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43326000 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40492000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2620000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2286000 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1865000 usd
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
9938000 usd
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
9282000 usd
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
7442000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
133000 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
300000 usd
CY2023 us-gaap Investment Income Dividend
InvestmentIncomeDividend
3000 usd
CY2022 us-gaap Investment Income Dividend
InvestmentIncomeDividend
100000 usd
CY2021 us-gaap Investment Income Dividend
InvestmentIncomeDividend
69000 usd
CY2023 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
55000 usd
CY2022 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
182000 usd
CY2021 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
2000 usd
CY2023 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-439000 usd
CY2022 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
0 usd
CY2021 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
0 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5323000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2850000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1360000 usd
CY2023 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
1502000 usd
CY2022 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
589000 usd
CY2021 us-gaap Equity Securities Fv Ni Realized Gain
EquitySecuritiesFvNiRealizedGain
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-748000 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-435000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-980000 usd
CY2023 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2022 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2021 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
15252000 usd
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
844000 usd
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-262000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
894000 usd
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-333000 usd
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2813000 usd
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1583000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-256000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3427000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1568000 usd
CY2023 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
252000 usd
CY2022 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-736000 usd
CY2021 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
56000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
511000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1768000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1581000 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1950000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1265000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1759000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-70000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
16000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1177000 usd
CY2023 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
17916000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1761000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1465000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1219000 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-57000 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-72000 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
154000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
282000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3956000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2610000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-4195000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2026000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2890000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
437000 usd
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-218000 usd
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-57000 usd
CY2023 dsx Payments For Drydocking
PaymentsForDrydocking
5646000 usd
CY2022 dsx Payments For Drydocking
PaymentsForDrydocking
16368000 usd
CY2021 dsx Payments For Drydocking
PaymentsForDrydocking
4531000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
70380000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
158859000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
89705000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29732000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
230302000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17393000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
36560000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4372000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
33731000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
10595000 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2023 dsx Payments For Proceeds From Time Deposits
PaymentsForProceedsFromTimeDeposits
-6500000 usd
CY2022 dsx Payments For Proceeds From Time Deposits
PaymentsForProceedsFromTimeDeposits
46500000 usd
CY2021 dsx Payments For Proceeds From Time Deposits
PaymentsForProceedsFromTimeDeposits
0 usd
CY2023 dsx Payments To Joint Ventures
PaymentsToJointVentures
0 usd
CY2022 dsx Payments To Joint Ventures
PaymentsToJointVentures
0 usd
CY2021 dsx Payments To Joint Ventures
PaymentsToJointVentures
375000 usd
CY2023 dsx Payments To Acquire Other Assets
PaymentsToAcquireOtherAssets
216000 usd
CY2022 dsx Payments To Acquire Other Assets
PaymentsToAcquireOtherAssets
0 usd
CY2021 dsx Payments To Acquire Other Assets
PaymentsToAcquireOtherAssets
0 usd
CY2023 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
771000 usd
CY2022 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0 usd
CY2021 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
1000000 usd
CY2023 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
25189000 usd
CY2022 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
0 usd
CY2021 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
0 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
2006000 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
667000 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1600000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24929000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-273097000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13363000 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
57696000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
275133000 usd
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
101279000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5266000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
79000 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2023 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
254000 usd
CY2023 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5769000 usd
CY2022 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5769000 usd
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5769000 usd
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
41427000 usd
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
79812000 usd
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8820000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3799000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
45369000 usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1724000 usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3302000 usd
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7594000 usd
CY2023 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
79842000 usd
CY2022 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
102839000 usd
CY2021 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
93170000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71145000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84878000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59189000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24164000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29360000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
43879000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97428000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126788000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82909000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121592000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97428000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126788000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101592000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76428000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110288000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
20000000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
21000000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121592000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
97428000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
126788000 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
7809000 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
136038000 usd
CY2021 us-gaap Noncash Or Part Noncash Acquisition Investments Acquired1
NoncashOrPartNoncashAcquisitionInvestmentsAcquired1
0 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
20571000 usd
CY2023 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 usd
CY2022 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
47782000 usd
CY2023 us-gaap Stock Issued1
StockIssued1
7809000 usd
CY2022 us-gaap Stock Issued1
StockIssued1
67909000 usd
CY2021 us-gaap Stock Issued1
StockIssued1
0 usd
CY2023 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
10000000 usd
CY2023 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
10000000 usd
CY2022 us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 usd
CY2022 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 usd
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 usd
CY2023 dsx Noncash Dividends
NoncashDividends
41521000 usd
CY2022 dsx Noncash Dividends
NoncashDividends
0 usd
CY2021 dsx Noncash Dividends
NoncashDividends
0 usd
CY2023 us-gaap Transfer To Investments
TransferToInvestments
0 usd
CY2022 us-gaap Transfer To Investments
TransferToInvestments
1370000 usd
CY2021 us-gaap Transfer To Investments
TransferToInvestments
441000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
46473000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
21306000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
19608000 usd
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
1999-03-08
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div id="TextBlockContainer1050" style="position:relative;line-height:normal;width:704px;height:86px;"><div id="TextContainer1050" style="position:relative;width:704px;z-index:1;"><div id="a20882" style="position:absolute;font-family:'Arial';font-weight:bold;font-style:italic;left:5px;top:0px;">b)<div style="display:inline-block;width:34px"> </div>Use<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>Estimates: </div><div id="a20886" style="position:absolute;font-family:'Arial';left:185px;top:0px;">The preparation<div style="display:inline-block;width:7px"> </div>of<div style="display:inline-block;width:5px"> </div>consolidated financial<div style="display:inline-block;width:7px"> </div>statements<div style="display:inline-block;width:5px"> </div>in<div style="display:inline-block;width:6px"> </div>conformity with<div style="display:inline-block;width:7px"> </div>U.S. </div><div id="a20887" style="position:absolute;font-family:'Arial';left:5px;top:17px;">generally accepted accounting principles<div style="display:inline-block;width:6px"> </div>requires management to make estimates<div style="display:inline-block;width:6px"> </div>and assumptions that </div><div id="a20888" style="position:absolute;font-family:'Arial';left:5px;top:34px;">affect the<div style="display:inline-block;width:6px"> </div>reported amounts<div style="display:inline-block;width:6px"> </div>of assets<div style="display:inline-block;width:6px"> </div>and liabilities<div style="display:inline-block;width:6px"> </div>and disclosure<div style="display:inline-block;width:6px"> </div>of contingent<div style="display:inline-block;width:6px"> </div>assets and<div style="display:inline-block;width:6px"> </div>liabilities at </div><div id="a20890" style="position:absolute;font-family:'Arial';left:5px;top:51px;">the<div style="display:inline-block;width:6px"> </div>date<div style="display:inline-block;width:5px"> </div>of<div style="display:inline-block;width:5px"> </div>the<div style="display:inline-block;width:6px"> </div>consolidated financial<div style="display:inline-block;width:7px"> </div>statements<div style="display:inline-block;width:5px"> </div>and the<div style="display:inline-block;width:7px"> </div>reported<div style="display:inline-block;width:5px"> </div>amounts of<div style="display:inline-block;width:7px"> </div>revenues<div style="display:inline-block;width:6px"> </div>and<div style="display:inline-block;width:6px"> </div>expenses </div><div id="a20891" style="position:absolute;font-family:'Arial';left:5px;top:68px;">during the reporting period.<div style="display:inline-block;width:8px"> </div>Actual results could differ from those estimates.</div></div></div>
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1206000 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
578000 usd
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022 us-gaap Depreciation
Depreciation
36986000 usd
CY2022 us-gaap Depreciation
Depreciation
36986000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1141128000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
191512000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
949616000 usd
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
61682000 usd
CY2023 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
61682000 usd
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
60655000 usd
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
21688000 usd
CY2023 dsx Property Plant And Equipment Disposals Net
PropertyPlantAndEquipmentDisposalsNet
38967000 usd
CY2023 dsx Property Plant And Equipment Disposal Due To Deconsolidation Of Subsidiary
PropertyPlantAndEquipmentDisposalDueToDeconsolidationOfSubsidiary
27908000 usd
CY2023 dsx Property Plant And Equipment Disposal Due To Deconsolidation Of Subsidiary
PropertyPlantAndEquipmentDisposalDueToDeconsolidationOfSubsidiary
27908000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<div id="TextBlockContainer1102" style="position:relative;line-height:normal;width:704px;height:592px;"><div id="TextContainer1102" style="position:relative;width:704px;z-index:1;"><div id="a21145" style="position:absolute;font-family:'Arial';font-weight:bold;font-style:italic;left:5px;top:0px;">l)<div style="display:inline-block;width:39px"> </div>Impairment<div style="display:inline-block;width:7px"> </div>of<div style="display:inline-block;width:7px"> </div>Long-Lived<div style="display:inline-block;width:6px"> </div>Assets: </div><div id="a21152" style="position:absolute;font-family:'Arial';left:306px;top:0px;">Long-lived<div style="display:inline-block;width:6px"> </div>assets<div style="display:inline-block;width:7px"> </div>are<div style="display:inline-block;width:7px"> </div>reviewed<div style="display:inline-block;width:7px"> </div>for<div style="display:inline-block;width:7px"> </div>impairment<div style="display:inline-block;width:6px"> </div>whenever </div><div id="a21157" style="position:absolute;font-family:'Arial';left:5px;top:17px;">events<div style="display:inline-block;width:7px"> </div>or<div style="display:inline-block;width:7px"> </div>changes<div style="display:inline-block;width:7px"> </div>in<div style="display:inline-block;width:7px"> </div>circumstances<div style="display:inline-block;width:6px"> </div>(such<div style="display:inline-block;width:7px"> </div>as<div style="display:inline-block;width:7px"> </div>market<div style="display:inline-block;width:7px"> </div>conditions,<div style="display:inline-block;width:7px"> </div>obsolesce<div style="display:inline-block;width:7px"> </div>or<div style="display:inline-block;width:7px"> </div>damage<div style="display:inline-block;width:7px"> </div>to<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:7px"> </div>asset, </div><div id="a21158" style="position:absolute;font-family:'Arial';left:5px;top:34px;">potential<div style="display:inline-block;width:7px"> </div>sales<div style="display:inline-block;width:7px"> </div>and<div style="display:inline-block;width:7px"> </div>other<div style="display:inline-block;width:7px"> </div>business<div style="display:inline-block;width:7px"> </div>plans)<div style="display:inline-block;width:7px"> </div>indicate<div style="display:inline-block;width:7px"> </div>that<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:7px"> </div>carrying<div style="display:inline-block;width:7px"> </div>amount<div style="display:inline-block;width:7px"> </div>of<div style="display:inline-block;width:7px"> </div>an<div style="display:inline-block;width:7px"> </div>asset<div style="display:inline-block;width:7px"> </div>may<div style="display:inline-block;width:7px"> </div>not<div style="display:inline-block;width:7px"> </div>be </div><div id="a21166" style="position:absolute;font-family:'Arial';left:5px;top:51px;">recoverable.<div style="display:inline-block;width:6px"> </div>When<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>estimate<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>undiscounted projected<div style="display:inline-block;width:7px"> </div>net<div style="display:inline-block;width:6px"> </div>operating<div style="display:inline-block;width:5px"> </div>cash<div style="display:inline-block;width:6px"> </div>flows,<div style="display:inline-block;width:6px"> </div>excluding interest </div><div id="a21167" style="position:absolute;font-family:'Arial';left:5px;top:68px;">charges, expected<div style="display:inline-block;width:6px"> </div>to be<div style="display:inline-block;width:6px"> </div>generated by<div style="display:inline-block;width:6px"> </div>the use<div style="display:inline-block;width:6px"> </div>of an<div style="display:inline-block;width:6px"> </div>asset over<div style="display:inline-block;width:6px"> </div>its remaining<div style="display:inline-block;width:6px"> </div>useful life<div style="display:inline-block;width:6px"> </div>and its<div style="display:inline-block;width:6px"> </div>eventual </div><div id="a21171" style="position:absolute;font-family:'Arial';left:5px;top:84px;">disposition<div style="display:inline-block;width:8px"> </div>is<div style="display:inline-block;width:8px"> </div>less<div style="display:inline-block;width:8px"> </div>than<div style="display:inline-block;width:8px"> </div>its<div style="display:inline-block;width:8px"> </div>carrying<div style="display:inline-block;width:8px"> </div>amount,<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:8px"> </div>Company<div style="display:inline-block;width:8px"> </div>evaluates<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:8px"> </div>asset<div style="display:inline-block;width:8px"> </div>for<div style="display:inline-block;width:8px"> </div>impairment<div style="display:inline-block;width:8px"> </div>loss. </div><div id="a21177" style="position:absolute;font-family:'Arial';left:5px;top:101px;">Measurement of<div style="display:inline-block;width:6px"> </div>the impairment<div style="display:inline-block;width:6px"> </div>loss is<div style="display:inline-block;width:6px"> </div>based on<div style="display:inline-block;width:6px"> </div>the fair<div style="display:inline-block;width:6px"> </div>value of<div style="display:inline-block;width:6px"> </div>the asset,<div style="display:inline-block;width:6px"> </div>determined mainly<div style="display:inline-block;width:6px"> </div>by third </div><div id="a21184" style="position:absolute;font-family:'Arial';left:5px;top:118px;">party valuations.<div style="display:inline-block;width:4px"> </div></div><div id="a21187" style="position:absolute;font-family:'Arial';left:5px;top:152px;">For vessels, the Company calculates undiscounted projected net operating cash flows by considering the </div><div id="a21188" style="position:absolute;font-family:'Arial';left:5px;top:169px;">historical and<div style="display:inline-block;width:5px"> </div>estimated vessels’ performance<div style="display:inline-block;width:5px"> </div>and utilization with<div style="display:inline-block;width:6px"> </div>the significant assumption<div style="display:inline-block;width:6px"> </div>being future </div><div id="a21189" style="position:absolute;font-family:'Arial';left:5px;top:186px;">charter rates for the unfixed days, using<div style="display:inline-block;width:5px"> </div>the most recent </div><div id="a21189_58_2" style="position:absolute;font-family:'Arial';left:376px;top:186px;">10</div><div id="a21189_60_48" style="position:absolute;font-family:'Arial';left:392px;top:186px;">-year average of historical 1 year time charter </div><div id="a21193" style="position:absolute;font-family:'Arial';left:5px;top:202px;">rates available<div style="display:inline-block;width:2px"> </div>for each<div style="display:inline-block;width:2px"> </div>type of<div style="display:inline-block;width:2px"> </div>vessel over<div style="display:inline-block;width:2px"> </div>the remaining<div style="display:inline-block;width:2px"> </div>estimated life<div style="display:inline-block;width:2px"> </div>of each<div style="display:inline-block;width:2px"> </div>vessel, net<div style="display:inline-block;width:2px"> </div>of commissions. </div><div id="a21194" style="position:absolute;font-family:'Arial';left:5px;top:219px;">Historical<div style="display:inline-block;width:6px"> </div>ten-year<div style="display:inline-block;width:6px"> </div>blended<div style="display:inline-block;width:6px"> </div>average<div style="display:inline-block;width:6px"> </div>one-year<div style="display:inline-block;width:6px"> </div>time<div style="display:inline-block;width:6px"> </div>charter<div style="display:inline-block;width:6px"> </div>rates<div style="display:inline-block;width:6px"> </div>are<div style="display:inline-block;width:6px"> </div>in<div style="display:inline-block;width:6px"> </div>line<div style="display:inline-block;width:6px"> </div>with<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>Company’s<div style="display:inline-block;width:6px"> </div>overall </div><div id="a21201" style="position:absolute;font-family:'Arial';left:5px;top:236px;">chartering strategy,<div style="display:inline-block;width:6px"> </div>they reflect the<div style="display:inline-block;width:6px"> </div>full operating history<div style="display:inline-block;width:6px"> </div>of vessels of<div style="display:inline-block;width:6px"> </div>the same type<div style="display:inline-block;width:6px"> </div>and particulars with </div><div id="a21202" style="position:absolute;font-family:'Arial';left:5px;top:253px;">the Company’s<div style="display:inline-block;width:6px"> </div>operating fleet<div style="display:inline-block;width:6px"> </div>and they<div style="display:inline-block;width:5px"> </div>cover at<div style="display:inline-block;width:6px"> </div>least a<div style="display:inline-block;width:6px"> </div>full business<div style="display:inline-block;width:6px"> </div>cycle, where<div style="display:inline-block;width:6px"> </div>applicable. When the </div><div id="a21203" style="position:absolute;font-family:'Arial';left:5px;top:270px;">10</div><div id="a21203_2_106" style="position:absolute;font-family:'Arial';left:22px;top:270px;">-year average of historical 1 year time charter rates is<div style="display:inline-block;width:6px"> </div>not available for a type of vessels, the Company </div><div id="a21207" style="position:absolute;font-family:'Arial';left:5px;top:287px;">uses the average of historical 1 year time charter rates<div style="display:inline-block;width:3px"> </div>of the available period. Other assumptions used in </div><div id="a21208" style="position:absolute;font-family:'Arial';left:5px;top:304px;">developing estimates of<div style="display:inline-block;width:3px"> </div>future undiscounted cash<div style="display:inline-block;width:2px"> </div>flow are charter rates<div style="display:inline-block;width:2px"> </div>calculated for the<div style="display:inline-block;width:2px"> </div>fixed days using </div><div id="a21210" style="position:absolute;font-family:'Arial';left:5px;top:321px;">the<div style="display:inline-block;width:6px"> </div>fixed<div style="display:inline-block;width:6px"> </div>charter<div style="display:inline-block;width:6px"> </div>rate<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>each<div style="display:inline-block;width:6px"> </div>vessel<div style="display:inline-block;width:6px"> </div>from<div style="display:inline-block;width:6px"> </div>existing<div style="display:inline-block;width:6px"> </div>time<div style="display:inline-block;width:6px"> </div>charters,<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>expected<div style="display:inline-block;width:6px"> </div>outflows<div style="display:inline-block;width:6px"> </div>for<div style="display:inline-block;width:6px"> </div>scheduled </div><div id="a21211" style="position:absolute;font-family:'Arial';left:5px;top:337px;">vessels’ maintenance; vessel<div style="display:inline-block;width:6px"> </div>operating expenses; fleet<div style="display:inline-block;width:6px"> </div>utilization, and the<div style="display:inline-block;width:6px"> </div>vessels’ residual value<div style="display:inline-block;width:6px"> </div>if sold </div><div id="a21212" style="position:absolute;font-family:'Arial';left:5px;top:354px;">for scrap.<div style="display:inline-block;width:5px"> </div>Assumptions are<div style="display:inline-block;width:2px"> </div>in line<div style="display:inline-block;width:2px"> </div>with the<div style="display:inline-block;width:2px"> </div>Company’s historical<div style="display:inline-block;width:2px"> </div>performance and<div style="display:inline-block;width:2px"> </div>its expectations<div style="display:inline-block;width:2px"> </div>for future </div><div id="a21213" style="position:absolute;font-family:'Arial';left:5px;top:371px;">fleet<div style="display:inline-block;width:6px"> </div>utilization<div style="display:inline-block;width:6px"> </div>under<div style="display:inline-block;width:6px"> </div>its<div style="display:inline-block;width:6px"> </div>current<div style="display:inline-block;width:6px"> </div>fleet<div style="display:inline-block;width:6px"> </div>deployment<div style="display:inline-block;width:6px"> </div>strategy.<div style="display:inline-block;width:7px"> </div>This<div style="display:inline-block;width:6px"> </div>calculation<div style="display:inline-block;width:6px"> </div>is<div style="display:inline-block;width:6px"> </div>then<div style="display:inline-block;width:6px"> </div>compared<div style="display:inline-block;width:6px"> </div>with<div style="display:inline-block;width:6px"> </div>the </div><div id="a21214" style="position:absolute;font-family:'Arial';left:5px;top:388px;">vessels’ net book<div style="display:inline-block;width:5px"> </div>value plus unamortized deferred<div style="display:inline-block;width:5px"> </div>costs. The difference<div style="display:inline-block;width:6px"> </div>between the carrying amount<div style="display:inline-block;width:6px"> </div>of </div><div id="a21217" style="position:absolute;font-family:'Arial';left:5px;top:405px;">the vessel plus<div style="display:inline-block;width:6px"> </div>unamortized deferred costs<div style="display:inline-block;width:5px"> </div>and their fair<div style="display:inline-block;width:6px"> </div>value is recognized<div style="display:inline-block;width:6px"> </div>in the Company's<div style="display:inline-block;width:6px"> </div>accounts </div><div id="a21218" style="position:absolute;font-family:'Arial';left:5px;top:422px;">as impairment loss. </div><div id="a21221" style="position:absolute;font-family:'Arial';left:5px;top:455px;">The Company’s impairment assessment did not result in the </div><div id="a21221_58_25" style="position:absolute;font-family:'Arial';left:401px;top:455px;-sec-ix-hidden:ID_508;">recognition of impairment</div><div id="a21221_83_19" style="position:absolute;font-family:'Arial';left:566px;top:455px;"><div style="display:inline-block;width:4px"> </div>on any vessel and </div><div id="a21228" style="position:absolute;font-family:'Arial';left:5px;top:472px;">therefore </div><div id="a21228_10_2" style="position:absolute;font-family:'Arial';left:68px;top:472px;">no</div><div id="a21228_12_68" style="position:absolute;font-family:'Arial';left:85px;top:472px;"><div style="display:inline-block;width:4px"> </div>impairment loss was identified or recorded in 2023, 2022<div style="display:inline-block;width:3px"> </div>and 2021. </div><div id="a21238" style="position:absolute;font-family:'Arial';left:5px;top:506px;">For property<div style="display:inline-block;width:6px"> </div>and equipment,<div style="display:inline-block;width:6px"> </div>the Company<div style="display:inline-block;width:6px"> </div>determines undiscounted<div style="display:inline-block;width:6px"> </div>projected net<div style="display:inline-block;width:6px"> </div>operating cash<div style="display:inline-block;width:6px"> </div>flows </div><div id="a21241" style="position:absolute;font-family:'Arial';left:5px;top:523px;">by<div style="display:inline-block;width:6px"> </div>considering<div style="display:inline-block;width:6px"> </div>an<div style="display:inline-block;width:6px"> </div>estimated<div style="display:inline-block;width:6px"> </div>monthly<div style="display:inline-block;width:6px"> </div>rent<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>Company<div style="display:inline-block;width:6px"> </div>would<div style="display:inline-block;width:6px"> </div>have<div style="display:inline-block;width:6px"> </div>to<div style="display:inline-block;width:6px"> </div>pay<div style="display:inline-block;width:6px"> </div>in<div style="display:inline-block;width:6px"> </div>order<div style="display:inline-block;width:6px"> </div>to<div style="display:inline-block;width:6px"> </div>lease<div style="display:inline-block;width:6px"> </div>a<div style="display:inline-block;width:6px"> </div>similar </div><div id="a21242" style="position:absolute;font-family:'Arial';left:5px;top:540px;">property, during the useful<div style="display:inline-block;width:2px"> </div>life of the<div style="display:inline-block;width:2px"> </div>building. No<div style="display:inline-block;width:3px"> </div>impairment loss<div style="display:inline-block;width:3px"> </div>was identified or<div style="display:inline-block;width:2px"> </div>recorded for<div style="display:inline-block;width:3px"> </div>2023,<div style="display:inline-block;width:3px"> </div>2022 </div><div id="a21248" style="position:absolute;font-family:'Arial';left:5px;top:557px;">and 2021 and<div style="display:inline-block;width:2px"> </div>the Company has<div style="display:inline-block;width:2px"> </div>not identified any<div style="display:inline-block;width:2px"> </div>other facts or<div style="display:inline-block;width:3px"> </div>circumstances that<div style="display:inline-block;width:3px"> </div>would require<div style="display:inline-block;width:3px"> </div>the write </div><div id="a21252" style="position:absolute;font-family:'Arial';left:5px;top:574px;">down of the value of its land or building in the near future.</div></div></div>
CY2023 dsx Time Period For Measurement Of Time Charter Rate Input For Calculation Of Vessel Impairments
TimePeriodForMeasurementOfTimeCharterRateInputForCalculationOfVesselImpairments
P10Y
CY2023 dsx Time Period For Measurement Of Time Charter Rate Input For Calculation Of Vessel Impairments
TimePeriodForMeasurementOfTimeCharterRateInputForCalculationOfVesselImpairments
P10Y
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id="TextBlockContainer1119" style="position:relative;line-height:normal;width:704px;height:136px;"><div id="TextContainer1119" style="position:relative;width:704px;z-index:1;"><div id="a21395" style="position:absolute;font-family:'Arial';font-weight:bold;font-style:italic;left:5px;top:0px;">p)<div style="display:inline-block;width:34px"> </div>Concentration of<div style="display:inline-block;width:7px"> </div>Credit<div style="display:inline-block;width:5px"> </div>Risk</div><div id="a21399" style="position:absolute;font-family:'Arial';left:257px;top:0px;">:<div style="display:inline-block;width:6px"> </div>Financial instruments,<div style="display:inline-block;width:6px"> </div>which potentially<div style="display:inline-block;width:7px"> </div>subject<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:5px"> </div>Company to </div><div id="a21400" style="position:absolute;font-family:'Arial';left:5px;top:17px;">significant<div style="display:inline-block;width:6px"> </div>concentrations<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>credit<div style="display:inline-block;width:6px"> </div>risk,<div style="display:inline-block;width:6px"> </div>consist<div style="display:inline-block;width:6px"> </div>principally<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>cash<div style="display:inline-block;width:6px"> </div>and<div style="display:inline-block;width:6px"> </div>trade<div style="display:inline-block;width:6px"> </div>accounts<div style="display:inline-block;width:6px"> </div>receivable.<div style="display:inline-block;width:6px"> </div>The </div><div id="a21401" style="position:absolute;font-family:'Arial';left:5px;top:34px;">Company<div style="display:inline-block;width:6px"> </div>places<div style="display:inline-block;width:6px"> </div>its<div style="display:inline-block;width:6px"> </div>temporary<div style="display:inline-block;width:6px"> </div>cash<div style="display:inline-block;width:6px"> </div>investments,<div style="display:inline-block;width:6px"> </div>consisting<div style="display:inline-block;width:6px"> </div>mostly<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>deposits,<div style="display:inline-block;width:6px"> </div>with<div style="display:inline-block;width:6px"> </div>various<div style="display:inline-block;width:6px"> </div>qualified </div><div id="a21403" style="position:absolute;font-family:'Arial';left:5px;top:51px;">financial<div style="display:inline-block;width:6px"> </div>institutions<div style="display:inline-block;width:6px"> </div>and<div style="display:inline-block;width:6px"> </div>performs<div style="display:inline-block;width:6px"> </div>periodic<div style="display:inline-block;width:6px"> </div>evaluations<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>relative<div style="display:inline-block;width:6px"> </div>credit<div style="display:inline-block;width:6px"> </div>standing<div style="display:inline-block;width:6px"> </div>of<div style="display:inline-block;width:6px"> </div>those<div style="display:inline-block;width:6px"> </div>financial </div><div id="a21404" style="position:absolute;font-family:'Arial';left:5px;top:68px;">institutions that<div style="display:inline-block;width:6px"> </div>are considered<div style="display:inline-block;width:6px"> </div>in the<div style="display:inline-block;width:6px"> </div>Company’s investment<div style="display:inline-block;width:6px"> </div>strategy.<div style="display:inline-block;width:6px"> </div>The Company<div style="display:inline-block;width:6px"> </div>limits its<div style="display:inline-block;width:6px"> </div>credit risk </div><div id="a21405" style="position:absolute;font-family:'Arial';left:5px;top:85px;">with accounts receivable<div style="display:inline-block;width:3px"> </div>by performing ongoing credit<div style="display:inline-block;width:2px"> </div>evaluations of its customers’<div style="display:inline-block;width:2px"> </div>financial condition and </div><div id="a21407" style="position:absolute;font-family:'Arial';left:5px;top:101px;">generally<div style="display:inline-block;width:6px"> </div>does<div style="display:inline-block;width:6px"> </div>not<div style="display:inline-block;width:6px"> </div>require<div style="display:inline-block;width:6px"> </div>collateral<div style="display:inline-block;width:6px"> </div>for<div style="display:inline-block;width:6px"> </div>its<div style="display:inline-block;width:6px"> </div>accounts<div style="display:inline-block;width:6px"> </div>receivable<div style="display:inline-block;width:6px"> </div>and<div style="display:inline-block;width:6px"> </div>does<div style="display:inline-block;width:6px"> </div>not<div style="display:inline-block;width:6px"> </div>have<div style="display:inline-block;width:6px"> </div>any<div style="display:inline-block;width:6px"> </div>agreements<div style="display:inline-block;width:6px"> </div>to </div><div id="a21408" style="position:absolute;font-family:'Arial';left:5px;top:118px;">mitigate credit risk.</div></div></div>
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
810429000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
166979000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
643450000 usd
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
358504000 usd
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
358504000 usd
CY2023 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div id="TextBlockContainer1199" style="position:relative;line-height:normal;width:704px;height:137px;"><div id="TextContainer1199" style="position:relative;width:704px;z-index:1;"><div id="a21997" style="position:absolute;font-family:'Arial';font-weight:bold;font-style:italic;left:5px;top:0px;">ad)<div style="display:inline-block;width:26px"> </div>Guarantees: </div><div id="a22001" style="position:absolute;font-family:'Arial';left:148px;top:0px;">Guarantees<div style="display:inline-block;width:9px"> </div>issued<div style="display:inline-block;width:9px"> </div>by<div style="display:inline-block;width:9px"> </div>the<div style="display:inline-block;width:9px"> </div>Company,<div style="display:inline-block;width:10px"> </div>excluding<div style="display:inline-block;width:9px"> </div>those<div style="display:inline-block;width:9px"> </div>that<div style="display:inline-block;width:9px"> </div>guarantee<div style="display:inline-block;width:9px"> </div>its<div style="display:inline-block;width:9px"> </div>own </div><div id="a22002" style="position:absolute;font-family:'Arial';left:5px;top:17px;">performance, are recognized at fair<div style="display:inline-block;width:5px"> </div>value at the time the<div style="display:inline-block;width:6px"> </div>guarantees are issued, or upon deconsolidation </div><div id="a22003" style="position:absolute;font-family:'Arial';left:5px;top:34px;">of<div style="display:inline-block;width:7px"> </div>a<div style="display:inline-block;width:7px"> </div>subsidiary.<div style="display:inline-block;width:8px"> </div>A<div style="display:inline-block;width:7px"> </div>liability<div style="display:inline-block;width:7px"> </div>for<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:7px"> </div>fair<div style="display:inline-block;width:7px"> </div>value<div style="display:inline-block;width:7px"> </div>of<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:7px"> </div>obligation<div style="display:inline-block;width:7px"> </div>undertaken<div style="display:inline-block;width:7px"> </div>in<div style="display:inline-block;width:7px"> </div>issuing<div style="display:inline-block;width:7px"> </div>the<div style="display:inline-block;width:7px"> </div>guarantee<div style="display:inline-block;width:7px"> </div>is </div><div id="a22005" style="position:absolute;font-family:'Arial';left:5px;top:51px;">recognized. If it becomes probable that<div style="display:inline-block;width:2px"> </div>the Company will have to perform<div style="display:inline-block;width:2px"> </div>under a guarantee (Note 10(c)), </div><div id="a22008" style="position:absolute;font-family:'Arial';left:5px;top:68px;">the Company<div style="display:inline-block;width:6px"> </div>will recognize an<div style="display:inline-block;width:6px"> </div>additional liability if<div style="display:inline-block;width:6px"> </div>the amount<div style="display:inline-block;width:6px"> </div>of the<div style="display:inline-block;width:6px"> </div>loss can<div style="display:inline-block;width:6px"> </div>be reasonably<div style="display:inline-block;width:5px"> </div>estimated. </div><div id="a22009" style="position:absolute;font-family:'Arial';left:5px;top:84px;">The<div style="display:inline-block;width:6px"> </div>recognition<div style="display:inline-block;width:5px"> </div>of<div style="display:inline-block;width:6px"> </div>fair<div style="display:inline-block;width:5px"> </div>value is<div style="display:inline-block;width:7px"> </div>not<div style="display:inline-block;width:6px"> </div>required for<div style="display:inline-block;width:7px"> </div>certain<div style="display:inline-block;width:6px"> </div>guarantees such<div style="display:inline-block;width:7px"> </div>as<div style="display:inline-block;width:6px"> </div>the<div style="display:inline-block;width:6px"> </div>parent's guarantee<div style="display:inline-block;width:7px"> </div>of<div style="display:inline-block;width:6px"> </div>a </div><div id="a22012" style="position:absolute;font-family:'Arial';left:5px;top:101px;">subsidiary's debt<div style="display:inline-block;width:6px"> </div>to a<div style="display:inline-block;width:6px"> </div>third party.<div style="display:inline-block;width:7px"> </div>For those<div style="display:inline-block;width:6px"> </div>guarantees excluded<div style="display:inline-block;width:6px"> </div>from the<div style="display:inline-block;width:6px"> </div>above guidance<div style="display:inline-block;width:6px"> </div>requiring the </div><div id="a22013" style="position:absolute;font-family:'Arial';left:5px;top:118px;">fair value recognition provision of the liability, financial statement disclosures of such items are made.</div></div></div>
CY2023 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1313000 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
511000 usd
CY2021 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
1432000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
20729000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
17916000 usd
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
2813000 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
15080000 usd
CY2023Q1 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
14000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23198000 usd
CY2023Q1 us-gaap Deferred Costs
DeferredCosts
405000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4995000 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
17998000 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
328000 usd
CY2023 us-gaap Depreciation
Depreciation
44231000 usd
CY2022 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
1370000 usd
CY2022 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
1370000 usd
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
29175000 usd
CY2022 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
12453000 usd
CY2022 dsx Property Plant And Equipment Disposals Net
PropertyPlantAndEquipmentDisposalsNet
16722000 usd
CY2023 us-gaap Depreciation
Depreciation
44231000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1114247000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
214055000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
900192000 usd
CY2022 us-gaap Transfer To Investments
TransferToInvestments
1370000 usd
CY2021Q4 dsx Property And Equipment Gross
PropertyAndEquipmentGross
28269000 usd
CY2021Q4 dsx Accumulated Depreciation And Amortization Property And Equipment
AccumulatedDepreciationAndAmortizationPropertyAndEquipment
5427000 usd
CY2021Q4 dsx Property And Equipment Net
PropertyAndEquipmentNet
22842000 usd
CY2022 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
667000 usd
CY2022 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
667000 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
546000 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
546000 usd
CY2022Q4 dsx Property And Equipment Gross
PropertyAndEquipmentGross
28936000 usd
CY2022Q4 dsx Accumulated Depreciation And Amortization Property And Equipment
AccumulatedDepreciationAndAmortizationPropertyAndEquipment
5973000 usd
CY2022Q4 dsx Property And Equipment Net
PropertyAndEquipmentNet
22963000 usd
CY2023 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2006000 usd
CY2023 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
2006000 usd
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
687000 usd
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
687000 usd
CY2023Q4 dsx Property And Equipment Gross
PropertyAndEquipmentGross
30942000 usd
CY2023Q4 dsx Accumulated Depreciation And Amortization Property And Equipment
AccumulatedDepreciationAndAmortizationPropertyAndEquipment
6660000 usd
CY2023Q4 dsx Property And Equipment Net
PropertyAndEquipmentNet
24282000 usd
CY2023Q4 us-gaap Unsecured Debt
UnsecuredDebt
119100000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
125000000 usd
CY2023Q4 us-gaap Secured Debt
SecuredDebt
397857000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
405120000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
516957000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
530120000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6314000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7609000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
510643000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
522511000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
133337000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
49512000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
91495000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
461131000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
431016000 usd
CY2023Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
129000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
568000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
51783000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
51783000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
170883000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
152696000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
62026000 usd
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
27786000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
516957000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
133337000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
142370000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
132129000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
140931000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
9221000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8802000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
122908000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
132129000 usd
CY2023Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P7Y8M12D
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0483 pure
CY2023 us-gaap Sublease Income
SubleaseIncome
34560000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
9437000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
9808000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
10224000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
10661000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
11151000 usd
CY2023Q4 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
82056000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1750000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.54
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
2822753 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.05
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6793836 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.45
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
9938000 usd
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
9282000 usd
CY2022 us-gaap Insurance Recoveries
InsuranceRecoveries
1789000 usd
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
127297000 usd
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
24629000 usd
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
9454000 usd
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
725000 usd
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
162105000 usd
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
79812000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15965000 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12424000 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13041000 usd
CY2021Q4 us-gaap Dividends Paidinkind
DividendsPaidinkind
40509000 usd
CY2022Q4 us-gaap Dividends Paidinkind
DividendsPaidinkind
18189000 usd
CY2023Q2 us-gaap Dividends Paidinkind
DividendsPaidinkind
10761000 usd
CY2023Q2 dsx Dividends Paid In Kind Per Share
DividendsPaidInKindPerShare
0.10
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
22613070 shares
CY2023Q4 dsx Warrants Exercise Price Per Warrant
WarrantsExercisePricePerWarrant
4
CY2023Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
7914000 usd
CY2023Q4 dsx Warrants Fair Value Per Share
WarrantsFairValuePerShare
0.35
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6332000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1583000 usd
CY2023 dsx Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
13444759 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2423012 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.95
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
8260000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.85
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1168363 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
3.20
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
9514649 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.83
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1470000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.15
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
3118060 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.86
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7866589 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.07
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
7442000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
14880000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
16873000 usd
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M12D
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
9 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
18487393 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1 shares
CY2022 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2023 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
13331000 usd
CY2022 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
14412000 usd
CY2021 us-gaap Direct Costs Of Leased And Rented Property Or Equipment
DirectCostsOfLeasedAndRentedPropertyOrEquipment
10794000 usd
CY2023 us-gaap Fuel Costs
FuelCosts
474000 usd
CY2022 us-gaap Fuel Costs
FuelCosts
8100000 usd
CY2021 us-gaap Fuel Costs
FuelCosts
5955000 usd
CY2023 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
764000 usd
CY2022 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
630000 usd
CY2021 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
731000 usd
CY2023 us-gaap Direct Operating Costs
DirectOperatingCosts
13621000 usd
CY2022 us-gaap Direct Operating Costs
DirectOperatingCosts
6942000 usd
CY2021 us-gaap Direct Operating Costs
DirectOperatingCosts
5570000 usd
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
39617000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
21983000 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
18067000 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
6786000 usd
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2735000 usd
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2620000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2286000 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1865000 usd
CY2023 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
308000 usd
CY2022 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
415000 usd
CY2021 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
307000 usd
CY2023 us-gaap Interest Expense
InterestExpense
49331000 usd
CY2022 us-gaap Interest Expense
InterestExpense
27419000 usd
CY2021 us-gaap Interest Expense
InterestExpense
20239000 usd
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1710513 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3257861 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3735059 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
49844000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
119063000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
57394000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44075000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
113294000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51625000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100166629 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80061040 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81121781 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2023 us-gaap Net Income Loss
NetIncomeLoss
49844000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
119063000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
57394000 usd
CY2023 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2022 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5769000 usd
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1583000 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
42492000 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
113294000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
51625000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100166629 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80061040 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81121781 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1710513 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3257861 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3735059 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101877142 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83318901 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84856840 shares
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.36
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2023Q4 dsx Us Source Income Percentage
UsSourceIncomePercentage
0.50 pure
CY2023Q4 dsx Tax Rate On Us Source Shipping Income
TaxRateOnUsSourceShippingIncome
0.04 pure
CY2023 dei Auditor Location
AuditorLocation
Athens, Greece

Files In Submission

Name View Source Status
0001562762-24-000080-index-headers.html Edgar Link pending
0001562762-24-000080-index.html Edgar Link pending
0001562762-24-000080.txt Edgar Link pending
0001562762-24-000080-xbrl.zip Edgar Link pending
dsx-20231231.htm Edgar Link pending
dsx-20231231.xsd Edgar Link pending
exhibit121.htm Edgar Link pending
exhibit122.htm Edgar Link pending
exhibit131.htm Edgar Link pending
exhibit132.htm Edgar Link pending
exhibit151.htm Edgar Link pending
dsx-20231231_cal.xml Edgar Link unprocessable
dsx-20231231_def.xml Edgar Link unprocessable
dsx-20231231_lab.xml Edgar Link unprocessable
dsx-20231231_pre.xml Edgar Link unprocessable
dsx-20231231_htm.xml Edgar Link completed
exhibit151p1i0.jpg Edgar Link pending
exhibit28.htm Edgar Link pending
exhibit449.htm Edgar Link pending
exhibit449p47i0.gif Edgar Link pending
exhibit449p47i1.gif Edgar Link pending
exhibit449p48i0.gif Edgar Link pending
exhibit449p48i2.gif Edgar Link pending
exhibit449p49i0.gif Edgar Link pending
exhibit449p50i1.gif Edgar Link pending
exhibit450.htm Edgar Link pending
exhibit450p15i0.gif Edgar Link pending
exhibit450p167i0.gif Edgar Link pending
exhibit450p2i0.jpg Edgar Link pending
exhibit451.htm Edgar Link pending
exhibit452.htm Edgar Link pending
exhibit452p162i0.gif Edgar Link pending
exhibit452p163i0.gif Edgar Link pending
exhibit452p164i0.gif Edgar Link pending
exhibit452p165i0.gif Edgar Link pending
exhibit452p165i1.gif Edgar Link pending
exhibit452p167i0.gif Edgar Link pending
exhibit452p2i0.jpg Edgar Link pending
exhibit453.htm Edgar Link pending
exhibit81.htm Edgar Link pending
Exhibit971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable